Prot #TMB01-301: "The ASCEND Study: A Phase III, Multicenter, Double Blinded Vehicle Controlled Study of TMB-001 - with an Optional Maximal Use Arm - in the Treatment of RXLI (X-linked) or ARCI Ichthyosis in Subjects Aged =6 Years"

Project: Research project

Project Details

StatusActive
Effective start/end date2/14/23 → 2/14/26

Funding

  • Advanced Clinical LLC (Prot #TMB01-301 // Prot #TMB01-301)
  • Timber Pharmaceuticals, Inc. (Prot #TMB01-301 // Prot #TMB01-301)